CARE-HF LTFU: CArdiac REsynchronization in Heart Failure Long-Term Follow-up
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00318357|
Recruitment Status : Unknown
Verified May 2008 by Medtronic Bakken Research Center.
Recruitment status was: Active, not recruiting
First Posted : April 26, 2006
Last Update Posted : June 4, 2008
|Condition or disease||Intervention/treatment|
|Heart Failure||Device: Medtronic CRT InSync® family devices|
|Study Type :||Observational|
|Estimated Enrollment :||550 participants|
|Official Title:||CARE-HF LTFU: CArdiac REsynchronization in Heart Failure Long-Term Follow-up|
|Study Start Date :||September 2006|
|Estimated Primary Completion Date :||July 2010|
|Estimated Study Completion Date :||July 2010|
In the CARE-HF study patients treated with standard medical treatment plus CRT were compared to patients treated with standard medical treatment.
Device: Medtronic CRT InSync® family devices
Implantation of CRT device and medical treatment according normal hospital routine.
Other Name: Resynchronisation system of the InSync® family
- All cause Mortality [ Time Frame: 4-year ]
Biospecimen Retention: None Retained
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00318357
|Hull Royal Infirmary - Academic Cardiology Unit|
|Cottingham, Kingston-Upon-Hull, United Kingdom, HU16 5JQ|
|Study Chair:||John Cleland, Professor||The University of Hull; Department of Cardiology; United Kingdom|